Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
This study is designed to investigate the potential effect of benralizumab on the antibody response to the seasonal influenza virus vaccine in patients 12-21 years of age with asthma. Benralizumab will be given subcutaneously (SC) at Weeks 0, 4, and 8 weeks, at which time benralizumab levels will reach steady state. Patients will then receive 1 dose of intramuscular (IM) seasonal influenza virus vaccine at Week 8 and samples drawn at Week 8 and Week 12 to measure the antibody response to the influenza virus
Age
12–21
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Female and male patients aged 12 to 21 years, inclusive, at the time of Visit 1
Weight of ≥40 kg
Documented history of current treatment with Inhaled corticosteroids (ICS) and long-acting β2 agonists (LABA)
Morning pre-bronchodilator forced expiratory volume in 1 second (FEV1) of \>50% predicted at Visit 1 or Visit 2.
Airway reversibility (FEV1 \>12% and 200 ml) demonstrated at Visit 1 or Visit 2 using the Maximum Post-bronchodilator Procedure OR
Airway reversibility documented in the previous 12 months prior to Visit 1
An exacerbation, 1 or more, that required oral corticosteroids in the previous year OR
Any condition assessed by patient recall over the previous 2-4 weeks
You may not be if
Clinically important pulmonary disease other than asthma
Known history of allergy or reaction to the Investigational Product formulation or influenza vaccine
Receipt of an influenza vaccine within 90 days prior to randomization
Poorly controlled asthma during the screening period that requires treatment with oral corticosteroids or a hospitalization/emergency room visit for the treatment of asthma
Acute illness or evidence of significant active infection or known influenza infection during the current flu season